Gilead Sciences (GILD)
Company | Ticker | Sector | Industry | Quality | PAR |
---|---|---|---|---|
Gilead Sciences | GILD | Healthcare | Drug Manufacturers - General | 38 | 7.6% |
Current Price ( 4/24 4:00PM EDT) | $67.08 | |||
CAPS Rating (Rate this stock on CAPS) | ||||
Expected Income Statement | ||||
Current Sales | 27,115.0 | |||
Sales Growth Forecast | 0.9% | |||
Net Profit Margin | 23.1% | |||
Projected Shares Outstanding | 1,234.95 | |||
EPS - Five year Forecast | $5.31 | |||
Average P/E Ratio | 15.0 | |||
Projected Average Price | $79.58 | |||
Price Appreciation (Annualized) | 3.5% | |||
Annual Dividend Yield | 4.1% | |||
Projected Annual Return | 7.6% | |||
Quality | ||||
Financial Strength | 40 | 10.0 | ||
EPS Stability | 38 | 9.4 | ||
Industry Sales Growth Rate | 4.0% | 2.8 | ||
Industry Net Profit Margin | 19.3% | 15.0 | ||
Calculated Quality Rating | 37.2 | |||
Fool CAPS | ||||
Total Players
3337
Outperforms
91
Underperforms
All-Stars (578)
569
Outperforms (98%)
9
Underperforms
|
||||
Fundamental Data Updated: 03/29/2024 |